Keyword search

Sort Help
entries

Results

All (31)

All (31) (0 to 10 of 31 results)

  • Articles and reports: 88-003-X200700210323
    Geography: Canada
    Description:

    Although nanotechnology can be thought of as a sector of its own, it is clear that nanotechnology is a cross-sector phenomenon with potentially significant impacts. Nanotechnologies can be found in areas as diverse as biotechnology and health, agriculture, electronics and computer technology, environment and energy, optics, and in materials and manufacturing.

    Release date: 2007-10-09

  • Articles and reports: 88-003-X200700210324
    Geography: Canada
    Description:

    Statistics Canada is actively involved with the international community in developing statistical information on nanotechnologies. This article summarizes the ongoing work of the OECD's newly-established Working Party on Nanotechnology, with particular emphasis on the role of Statistics Canada.

    Release date: 2007-10-09

  • Articles and reports: 88-003-X200700210325
    Geography: Canada
    Description:

    Innovative biotechnology firms are science-based firms which attempt to bring an application of biotechnology to the market. However, it is clear that a significant proportion of these firms derive no revenue from product sales while their products proceed through the various phases of testing and regulatory approval. In order to support their operations they must look to other sources of funding.

    Release date: 2007-10-09

  • Articles and reports: 88-003-X200700210326
    Geography: Canada
    Description:

    Although private investors and government funding agencies have learned that the biotechnology sector requires a funding model different from that of traditional manufacturing, there is a paucity of empirical research investigating the links between characteristics of the funding model and firm performance. The purpose of this article is to examine which funding sources have the greatest influence on firm growth.

    Release date: 2007-10-09

  • Articles and reports: 88-003-X20070019620
    Geography: Canada, Province or territory
    Description:

    Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.

    Release date: 2007-05-10

  • Articles and reports: 88-003-X20060029246
    Geography: Canada
    Description:

    While firms engaged in R&D services are part of the population of firms covered by the Research and Development in Canadian Industry (RDCI) survey and the Biotechnology Use and Development Survey (BUDS), this industry group is not covered by a typical industry survey. This means that there are no industry-specific figures for contribution to GDP or other typical measures of industrial activities and finances. However, data for the industry group are available from the Survey of Innovation 2003, along with other selected professional services. Data from that survey indicate that the establishments in R&D services in physical, engineering and life sciences may be part of a select and highly atypical group of firms and are discussed in this article.

    Release date: 2006-06-27

  • Articles and reports: 88-003-X20050028021
    Geography: Canada
    Description:

    Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.

    Release date: 2005-06-20

  • Articles and reports: 88-003-X20050017771
    Geography: Canada
    Description:

    Preliminary data indicate the biotechnology sector continued its phenomenal growth in Canada between 2001 and 2003, generating almost $4 billion in revenues. Biotechnology companies have more than quadrupled their revenues since 1997, making biotech a quickly growing activity.

    Release date: 2005-02-09

  • Articles and reports: 88-003-X20040037427
    Geography: Canada
    Description:

    A series of working papers on the transition from small to medium size is being derived from a joint project of Statistics Canada and the National Research Council's Industrial Research Assistance Program (NRC-IRAP). The project developed out of a need to better understand how and why certain businesses grow.

    Release date: 2004-10-29

  • Articles and reports: 88-003-X20040037432
    Geography: Canada
    Description:

    This article is based on a recent series of interviews with leaders of high growth biotechnology firms. It highlights the importance of financing, management strategies and qualified personnel for achieving high growth.

    Release date: 2004-10-29
Data (0)

Data (0) (0 results)

No content available at this time.

Analysis (31)

Analysis (31) (0 to 10 of 31 results)

  • Articles and reports: 88-003-X200700210323
    Geography: Canada
    Description:

    Although nanotechnology can be thought of as a sector of its own, it is clear that nanotechnology is a cross-sector phenomenon with potentially significant impacts. Nanotechnologies can be found in areas as diverse as biotechnology and health, agriculture, electronics and computer technology, environment and energy, optics, and in materials and manufacturing.

    Release date: 2007-10-09

  • Articles and reports: 88-003-X200700210324
    Geography: Canada
    Description:

    Statistics Canada is actively involved with the international community in developing statistical information on nanotechnologies. This article summarizes the ongoing work of the OECD's newly-established Working Party on Nanotechnology, with particular emphasis on the role of Statistics Canada.

    Release date: 2007-10-09

  • Articles and reports: 88-003-X200700210325
    Geography: Canada
    Description:

    Innovative biotechnology firms are science-based firms which attempt to bring an application of biotechnology to the market. However, it is clear that a significant proportion of these firms derive no revenue from product sales while their products proceed through the various phases of testing and regulatory approval. In order to support their operations they must look to other sources of funding.

    Release date: 2007-10-09

  • Articles and reports: 88-003-X200700210326
    Geography: Canada
    Description:

    Although private investors and government funding agencies have learned that the biotechnology sector requires a funding model different from that of traditional manufacturing, there is a paucity of empirical research investigating the links between characteristics of the funding model and firm performance. The purpose of this article is to examine which funding sources have the greatest influence on firm growth.

    Release date: 2007-10-09

  • Articles and reports: 88-003-X20070019620
    Geography: Canada, Province or territory
    Description:

    Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.

    Release date: 2007-05-10

  • Articles and reports: 88-003-X20060029246
    Geography: Canada
    Description:

    While firms engaged in R&D services are part of the population of firms covered by the Research and Development in Canadian Industry (RDCI) survey and the Biotechnology Use and Development Survey (BUDS), this industry group is not covered by a typical industry survey. This means that there are no industry-specific figures for contribution to GDP or other typical measures of industrial activities and finances. However, data for the industry group are available from the Survey of Innovation 2003, along with other selected professional services. Data from that survey indicate that the establishments in R&D services in physical, engineering and life sciences may be part of a select and highly atypical group of firms and are discussed in this article.

    Release date: 2006-06-27

  • Articles and reports: 88-003-X20050028021
    Geography: Canada
    Description:

    Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.

    Release date: 2005-06-20

  • Articles and reports: 88-003-X20050017771
    Geography: Canada
    Description:

    Preliminary data indicate the biotechnology sector continued its phenomenal growth in Canada between 2001 and 2003, generating almost $4 billion in revenues. Biotechnology companies have more than quadrupled their revenues since 1997, making biotech a quickly growing activity.

    Release date: 2005-02-09

  • Articles and reports: 88-003-X20040037427
    Geography: Canada
    Description:

    A series of working papers on the transition from small to medium size is being derived from a joint project of Statistics Canada and the National Research Council's Industrial Research Assistance Program (NRC-IRAP). The project developed out of a need to better understand how and why certain businesses grow.

    Release date: 2004-10-29

  • Articles and reports: 88-003-X20040037432
    Geography: Canada
    Description:

    This article is based on a recent series of interviews with leaders of high growth biotechnology firms. It highlights the importance of financing, management strategies and qualified personnel for achieving high growth.

    Release date: 2004-10-29
Reference (0)

Reference (0) (0 results)

No content available at this time.

Date modified: